Keythera Pharmaceuticals is a clinical-stage biotech fim focused on pioneering small molecule drugs that efectively combatcancers and autoimmune disorders. To build a robust portfolio of products, the company emplys a strategy that leverages itsaffinity based high throughput screening technological platform. By doing so, the company aims to expedite the process ofdiscovering and developing new drugs while also ensuring distinctiveness within its product pipelines
We have received your business plan. After completing an initial evaluation, our investment team will contact projects that align with our investment focus. Due to the volume of submissions, we appreciate your understanding if you do not receive a follow-up. We wish your project every success!
OK
This website uses cookies
This website uses cookies to improve your experience while you navigate through the website. You
can choose to opt-out if you wish. For more information, please refer to our
《Cookies》。